SV

Street Verdict

Analyst Scorecard

A record of what Harshad Borawake said publicly, with the source. Not advice.

“Overweight on financials, consumption, and pharma sectors. Recommends accumulating good quality companies at reasonable valuations, focusing on bottom-up ideas given the uncertain global macro setup, and remaining constructive on domestic companies.”
Nifty PharmaBullishCalled 27 May 2025
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Harshad Borawake’s full track record